NASDAQ:MENS Jyong Biotech (MENS) Stock Price, News & Analysis $2.06 -0.06 (-2.83%) Closing price 09/16/2026 04:00 PM EasternExtended Trading$2.06 0.00 (-0.24%) As of 09/16/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOwnershipSEC FilingsShort Interest About Jyong Biotech Stock (NASDAQ:MENS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Jyong Biotech alerts:Sign Up Key Stats Today's Range$2.02▼$2.2050-Day Range$1.99▼$2.7152-Week Range$1.43▼$67.00Volume27,547 shsAverage Volume35,509 shsMarket Capitalization$156.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Jyong Biotech Limited is a clinical-stage biopharmaceutical company focused on developing and commercializing botanical drug products. The company’s research is centered on plant-derived therapies for urological conditions, including disorders affecting the prostate and urinary system. Its product development activities have primarily targeted benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate that can cause urinary symptoms, as well as other prostate-related conditions. Jyong Biotech’s portfolio includes botanical drug candidates and related products intended to address unmet needs in urological care. The company is headquartered in China and conducts its research and development activities there. Jyong Biotech is listed on the Nasdaq Capital Market under the symbol MENS. Publicly available information provides limited detail about its broader geographic operations and executive leadership.AI Generated. May Contain Errors. Read More Receive MENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jyong Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MENS Stock News HeadlinesJyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal RoadshowSeptember 3, 2026 | globenewswire.comJyong Biotech Ltd. Ordinary Shares (MENS)July 29, 2026 | nasdaq.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. | Altimetry (Ad)Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing PartnershipsJuly 23, 2026 | globenewswire.comJyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International ConventionJuly 2, 2026 | globenewswire.comJyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live InterviewMay 29, 2026 | globenewswire.comJyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year Ended December 31, 2025May 15, 2026 | quiverquant.comQJyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025May 15, 2026 | globenewswire.comSee More Headlines MENS Stock Analysis - Frequently Asked Questions How have MENS shares performed this year? Jyong Biotech's stock was trading at $3.95 at the start of the year. Since then, MENS stock has decreased by 47.8% and is now trading at $2.06. When did Jyong Biotech IPO? Jyong Biotech (MENS) raised $21 million in an initial public offering (IPO) on Tuesday, June 17th 2025. The company issued 2,666,667 shares at $7.50-$8.50 per share. How do I buy shares of Jyong Biotech? Shares of MENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:MENS Previous SymbolNASDAQ:MENS CIK1954488 Webwww.jyongbio.com Phone(8862) 27325205FaxN/AEmployees27Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.45 Quick Ratio0.45 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-6.24Miscellaneous Outstanding Shares76,030,000Free FloatN/AMarket Cap$156.62 million OptionableN/A Beta2.24 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:MENS) was last updated on 9/17/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jyong Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jyong Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
